Bortezomib
- Product NDC
- 43598-865
- 11-digit product format
- 435980865
- Labeler code
- 43598
- Product ID
- 43598-865_616e7f9f-70d9-ffe4-83b4-451778dc18c0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bortexomib
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Dr.Reddy's Laboratories Inc
- Application
- NDA206927
- Marketing category
- NDA
- Marketing start
- 2019-11-01
- Marketing end
- 0000-00-00
- Substance
- BORTEZOMIB
- Active strength
- 4 mg/1
- Pharmacologic classes
- Proteasome Inhibitor [EPC],Proteasome Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43598-865-60 | 43598086560 | 1 VIAL, SINGLE-DOSE in 1 CARTON (43598-865-60) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE | 2019-11-01 | 0000-00-00 | No | No | Current |